Quercetin Dosing for Women vs Men: Sex-Specific Evidence Review
Expert Summary
Human quercetin pharmacokinetic studies show women achieve modestly higher plasma levels than men at equivalent doses (~15–20% higher Cmax and AUC), potentially due to lower body mass and CYP metabolism differences. Despite this, dosing recommendations in clinical trials have not been sex-differentiated; standard recommendations apply to both sexes with individual optimization.
Key Facts
- Hormonal interactions: Quercetin has weak estrogenic activity in vitro but shows no clinically meaningful estrogenic effects at supplement doses in humans. Unlike phytoestrogens (isoflavones), quercetin is not a clinically significant estrogen mimic.
- Women's cardiovascular priority: Post-menopausal women have rapidly increased cardiovascular risk. Quercetin's blood pressure reduction and endothelial protection are particularly relevant for this demographic, potentially more so than for men of equivalent age.
- Breast cancer concern resolved: Early in vitro data raised concerns about quercetin's estrogen-like effects potentially promoting ER+ breast cancer. Human epidemiological data, however, consistently shows quercetin-rich diets are associated with reduced breast cancer risk.
- Men's prostate benefit: Quercetin reduces chronic prostatitis symptoms in RCTs and inhibits prostate cancer cell proliferation in vitro. The anti-inflammatory effects in the prostate gland are a sex-specific benefit for men.
- Fertility consideration: High-dose quercetin inhibits sperm motility in vitro at very high concentrations. At supplement doses, no adverse fertility effects have been documented in humans. Couples trying to conceive may prefer moderate doses (<500 mg/day).
- BMI-adjusted dosing: If using precise dosing, heavier individuals (both sexes) may need higher doses to achieve equivalent plasma concentrations. Using body weight-adjusted dosing (as with fisetin: 8 mg/kg) for quercetin is an emerging approach without established clinical precedent.
Recommended Products
Frequently Asked Questions
Is quercetin safe during perimenopause?
Yes. Quercetin's weak estrogenic activity is not clinically significant and does not appear to affect perimenopausal hormone levels. Its anti-inflammatory and cardiovascular protective effects are particularly beneficial during this hormonal transition.
Do men and women need different quercetin protocols?
The fundamental protocol is similar: continuous low-dose (200–300 mg/day) for maintenance, burst dosing (500–1,000 mg for 2 days monthly) for senolytic purposes. Women may achieve adequate effects at the lower end of the dose range.
Does quercetin affect hormonal contraception?
No clinically significant interaction between quercetin and hormonal contraceptives has been documented. Theoretical CYP3A4 interactions at very high doses exist but are not relevant at typical supplement doses.
Scientific References
- Boots AW et al. Health effects of quercetin: from antioxidant to nutraceutical. European Journal of Pharmacology. 2008. PMID: 18417116
- Yamamoto Y et al. Quercetin metabolism in rat and human liver. Drug Metabolism and Disposition. 2004. PMID: 15039292